341
Views
5
CrossRef citations to date
0
Altmetric
Review

Severe Heloderma spp. envenomation: a review of the literature

ORCID Icon &
Pages 179-184 | Received 24 Sep 2020, Accepted 13 Nov 2020, Published online: 02 Dec 2020

References

  • Bogert CRD, Campo RD. The Gila monster and its allies. Bull Am Mus Nat Hist. 1956;109:1–238.
  • Reiserer RS, Schuett GWS, Beck D. Taxonomic reassessment and conservation status of the beaded lizard, Heloderma horridum (Squamata: Helodermatidae). Amphib Reptile Conserv. 2013;7(1):74–96.
  • Phisalix M. Effet de la morsure d’un lézard venimeux d’Arizona, l’Heloderma suspectum Cope. C R Acad Sci. 1911;152:1790–1792.
  • Weinstein SA, Smith TL, Kardong KV. Reptile venom glands form, function, and future. In Mackessy SP, editor. Handbook of venoms and toxins of reptiles. Boca Raton: Taylor & Francis, CRC Press; 2009. p. 76–84.
  • Koludarov I, Jackson TN, Sunagar K, et al. Fossilized venom: the unusually conserved venom profiles of Heloderma species (beaded lizards and Gila monsters). Toxins. 2014;6(12):3582–3595.
  • Sanggaard KW, Dyrlund TF, Thomsen LR, et al. Characterization of the Gila monster (Heloderma suspectum suspectum) venom proteome. J Proteomics. 2015;117:1–11.
  • Russell FE, Bogert CM. Gila monster: its biology, venom and bite—a review. Toxicon. 1981;19(3):341–359.
  • Raufman JP. Bioactive peptides from lizard venoms. Regul Pept. 1996;61(1):1–18.
  • Miller MF. Gila monster envenomation. Ann Emerg Med. 1995;25(5):720.
  • Amri K, Chippaux JP. Report of a severe Heloderma suspectum envenomation. Clin Toxicol. 2020;:1–4. DOI: 10.1080/15563650.2020.1804574.
  • French R, Brooks D, Ruha AM, et al. Gila monster (Heloderma suspectum) envenomation: Descriptive analysis of calls to United States Poison Centers with focus on Arizona cases. Clin Toxicol. 2015;53(1):60–70.
  • Woodson WD. Toxicity of Heloderma venom. Herpetologica. 1947;1:31–33.
  • Grant ML, Henderson LJ. A case of Gila monster poisoning with a summary of some previous accounts. Proc Iowa Acad Sci. 1957;64:686–697.
  • Duellman WE. A case of Heloderma poisoning. Copeia. 1950;1950(2):151.
  • Shannon FA. Case reports of two Gila monster bites. Herpetologica. 1953;9(3):125–127.
  • Albritton DC, Parrish HM, Allen ER. Venenation by the Mexican beaded lizard (Heloderma horridum): report of a case. S Dakota J Med. 1970;23(4):9–11.
  • Stahnke HL, Heffron WA, Lewis DL. Bite of the Gila monster. Rocky Mtn Med J. 1970;67:25–30.
  • Roller JA. Gila monster bite: a case report. Clin Toxicol. 1977;10(4):423–427.
  • Roller JA, Davis DH. Letter: Gila monster bite. JAMA. 1976;235(3):249–250.
  • Heitschel S. Near death from a Gila monster bite. J Emerg Nurs. 1986;12(5):259–262.
  • Piacentine J, Curry SC, Ryan PJ. Life-threatening anaphylaxis following Gila monster bite. Ann Emerg Med. 1986;15(8):959–961.
  • Streiffer RH. Bite of the venomous lizard, the Gila monster. Postgrad Med. 1986;79(2):297–302.
  • Bou-Abboud CF, Kardassakis DG. Acute myocardial infarction following a Gila monster (Heloderma suspectum) bite. West J Med. 1988;148(5):577–579.
  • Preston CA. Hypotension, myocardial infarction, and coagulopathy following Gila monster bite. J Emerg Med. 1989;7(1):37–40.
  • Hooker KR, Caravati EM, Hartsell SC. Gila monster envenomation [published correction appears in Ann Emerg Med 1995 Jan;25(1):47]. Ann Emerg Med. 1994;24(4):731–735.
  • Strimple PD, Tomassoni AJ, Otten EJ, et al. Report on envenomation by a Gila monster Heloderma suspectum with a discussion of venom apparatus, clinical findings, and treatment. Wilderness Environ Med. 1997;8(2):111–116.2.3.CO;2]
  • Cantrell FL. Envenomation by the Mexican beaded lizard: a case report. J Toxicol Clin Toxicol. 2003;41(3):241–244.
  • Ariano-Sánchez D. Envenomation by a wild Guatemalan Beaded Lizard Heloderma horridum charlesbogerti. Clin Toxicol. 2008;46(9):897–899.
  • French RN, Ash J, Brooks DE. Gila monster bite. Clin Toxicol. 2012;50(2):151–152.
  • Wong OF, Cheung WH, Fung HT, et al. A case of Gila monster (Heloderma suspectum) bite. Hong Kong J Emerg Med. 2018;25(6):362–365.
  • Hendon RA, Tu AT. Biochemical characterization of the lizard toxin gilatoxin. Biochemistry. 1981;20(12):3517–3522.
  • Alagón A, Possani LD, Smart J, et al. Helodermatine, a kallikrein-like, hypotensive enzyme from the venom of Heloderma horridum horridum (Mexican beaded lizard). J Exp Med. 1986;164(6):1835–1845.
  • Nikai T, Imai K, Sugihara H, et al. Isolation and characterization of horridum toxin with arginine ester hydrolase activity from Heloderma horridum (beaded lizard) venom. Arch Biochem Biophys. 1988;264(1):270–280.
  • Utaisincharoen P, Mackessy SP, Miller RA, et al. Complete primary structure and biochemical properties of gilatoxin, a serine protease with kallikrein-like and angiotensin-degrading activities. J Biol Chem. 1993;268(29):21975–21983.,
  • Bas M, Adams V, Suvorava T, et al. Nonallergic angioedema: role of bradykinin. Allergy. 2007;62(8):842–856.
  • Abroug F, Souheil E, Ouanes I, et al. Ouanes Besbes L. Scorpion-related cardiomyopathy: clinical characteristics, pathophysiology, and treatment. Clin Toxicol. 2015;53(6):511–518.
  • Madias JE. Scorpion envenomation cardiomyopathy: a promising model for takotsubo syndrome. Clin Toxicol. 2015;53(7):787
  • Patterson RA, Lee IS. Effects of Heloderma suspectum venom on blood coagulation. Toxicon. 1969;7(4):321–324.
  • Huang TF, Chiang HS. Effect on human platelet aggregation of phospholipase A2 purified from Heloderma horridum (beaded lizard) venom. Biochim Biophys Acta. 1994;1211(1):61–68.
  • Uddman R, Goadsby PJ, Jansen-Olesen I, et al. Helospectin-like peptides: immunochemical localization and effects on isolated cerebral arteries and on local cerebral blood flow in the cat. J Cereb Blood Flow Metab. 1999;19(1):61–67.
  • Cardell M, Cardell LO. Helospectin, induces a potent relaxation of human airways in vitro. Peptides. 2001;22(9):1359–1362.
  • Parker DS, Raufman JP, O'Donohue TL, et al. Amino acid sequences of helospectins, new members of the glucagon superfamily, found in Gila monster venom. J Biol Chem. 1984;259(19):11751–11755.,
  • Naruse S, Yasui A, Kishida S, et al. Helodermin has a VIP-like effect upon canine blood flow. Peptides. 1986;7(Suppl1):237–240.
  • Furman BL. The development of Byetta (exenatide) from the venom of the Gila monster as an anti-diabetic agent. Toxicon. 2012;59(4):464–471.
  • Russell FE. Snake venom poisoning. JB Lippincott Co, Philadelphia. 1980. 395–419.
  • Clements JA, Nimmo WS, Grant IS. Bioavailability, pharmacokinetics, and analgesic activity of ketamine in humans. J Pharm Sci. 1982;71(5):539–542.
  • Brandehoff N, Benjamin JM, Balde C, et al. Ketamine for pain control of snake envenomation in Guinea: a case series. Toxicon. 2020;187:82–85.
  • LoVecchio F, Klemens J, Welch S, et al. Antibiotics after rattlesnake envenomation. J Emerg Med. 2002;23(4):327–328.
  • Terry P, Mackway-Jones K. Towards evidence based emergency medicine: best BETs from the Manchester Royal Infirmary. The use of antibiotics in venomous snake bite. Emerg Med J. 2002;19(1):48–49.
  • Sachett JAG, da Silva IM, Alves EC, et al. Poor efficacy of preemptive amoxicillin clavulanate for preventing secondary infection from Bothrops snakebites in the Brazilian Amazon: a randomized controlled clinical trial. PLOS Negl Trop Dis. 2017;11(7):e0005745.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.